- Trials with a EudraCT protocol (60)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
60 result(s) found for: Circulatory System.
Displaying page 1 of 3.
EudraCT Number: 2013-002189-38 | Sponsor Protocol Number: 44945 | Start Date*: 2017-10-11 |
Sponsor Name:Erasmus Medical Center | ||
Full Title: OPTIMIZING PERIPHERAL CIRCULATION WITH VASODILATOR THERAPY IN CRITICALLY ILL PATIENTS WITH CIRCULATORY SHOCK: A PILOT STUDY | ||
Medical condition: Circulatory shock | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012639-13 | Sponsor Protocol Number: 28180 | Start Date*: 2009-06-29 | |||||||||||||||||||||
Sponsor Name:Meander Medical Centre | |||||||||||||||||||||||
Full Title: Combined intracutaneous and intraperitoneal anaesthesia for postoperative pain reduction after laparoscopic cholecystectomy | |||||||||||||||||||||||
Medical condition: Symptomatic gallstone disease | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000958-56 | Sponsor Protocol Number: 2019/375 | Start Date*: 2019-08-16 |
Sponsor Name:Helse Fonna | ||
Full Title: “Haemodynamic stability during induction of general anesthesia with propofol and remifentanil: A randomized, controlled, double-blind study comparing low vs high propofol doses.” | ||
Medical condition: In daily clinical work we observe a hypotensive effect and a reduction in HR when induction of general anesthesia is performed using propofol and remifentanil. It is difficult to differentiate the ... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005893-93 | Sponsor Protocol Number: 00909.043 | Start Date*: 2021-09-21 | |||||||||||
Sponsor Name:Uniwersytet Medyczny w Białymstoku | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled study evaluating levosimendan re-infusions in patients with severe heart failure with reduced left ventricular ejection fraction. | |||||||||||||
Medical condition: Ambulatory Heart Failure Patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004273-88 | Sponsor Protocol Number: ASK-1-2011 | Start Date*: 2011-09-21 | |||||||||||
Sponsor Name:Erling Bjerregaard Pedersen, Medicinsk forskningsafsnit, Regionshospitalet Holstebro | |||||||||||||
Full Title: Effect of hydroxyethyl starch on renal handling of sodium and water, vasoactive hormones,biomarkers and the circulatory system in patients undergoing laparoscopic nephrectomy | |||||||||||||
Medical condition: Patients undergoing laparoscopic nefrectomy in generel anesthesia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004906-12 | Sponsor Protocol Number: ASK-3-2011 | Start Date*: 2011-11-07 | |||||||||||
Sponsor Name:Erling Bjerregaard Pedersen, Medicinsk forskningsafsnit, Regionshospitalet Holstebro | |||||||||||||
Full Title: Effect of hydroxyethyl starch on renal handling of sodium and water, vasoactive hormones,biomarkers and the circulatory system in patients undergoing hip replacement surgery | |||||||||||||
Medical condition: Patients undergoing hip replacement in spinal anesthesia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002342-23 | Sponsor Protocol Number: 58166 | Start Date*: 2016-07-29 |
Sponsor Name:VU University Medical Center | ||
Full Title: The cardiovascular dose-response to supplemental oxygen in healthy volunteers | ||
Medical condition: Healthy cardiovascular system | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001401-25 | Sponsor Protocol Number: QHD00012 | Start Date*: 2019-09-27 | |||||||||||
Sponsor Name:Sanofi Pasteur Inc. | |||||||||||||
Full Title: Relative Effectiveness of a High-Dose Quadrivalent Influenza Vaccine versus a Standard-Dose Quadrivalent Influenza Vaccine in Subjects 65 Years of Age and Older | |||||||||||||
Medical condition: Prevention of influenza infection in adults from 65 years of age and older | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000122-21 | Sponsor Protocol Number: SJ-193 | Start Date*: 2012-08-10 | |||||||||||
Sponsor Name:Department of Neurology, Roskilde Hospital | |||||||||||||
Full Title: Acethylcholineesterase inhibition and orthostatic hypotension in patients with parkinsons disease | |||||||||||||
Medical condition: Ortostatic hypotension in patients with Parkinsons disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004560-21 | Sponsor Protocol Number: NL_ABR-43379 | Start Date*: 2013-04-03 |
Sponsor Name:Radboud University Nijmegen Medical Centre | ||
Full Title: The effect of ticagrelor on the adenosine system | ||
Medical condition: We will study in healthy volunteers the effect of ticagrelor on the vasodilator effect of dipyridamole | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-004460-66 | Sponsor Protocol Number: KARAASS-1 | Start Date*: 2014-04-01 | ||||||||||||||||
Sponsor Name:Jørgen Jeppesen | ||||||||||||||||||
Full Title: Oral potassium supplementation in healthy men - interactions with the renin-angiotensin-aldosterone system and the sympathetic nervous system | ||||||||||||||||||
Medical condition: Blood pressure regulation and hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-002416-27 | Sponsor Protocol Number: INFECIR2 | Start Date*: 2013-10-23 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Fundacio Clinic per a la recerca biomedica | ||||||||||||||||||||||||||||||||||||||
Full Title: Albumin administration in the prevention of hepatorenal syndrome and death in patients with cirrhosis, bacterial infections other than spontaneous bacterial peritonitis and high risk of hospital mo... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Patients with advanced cirrhosis (serum creatinine > 1.2 mg/dl, serum sodium < 130 mEq/l and/or serum bilirubin > 4 mg/dl), signs of systemic inflammation and urinary infection, pneumonia, skin/sof... | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: NO (Ongoing) ES (Ongoing) IT (Prematurely Ended) BE (Prematurely Ended) DE (Prematurely Ended) AT (Prematurely Ended) DK (Prematurely Ended) IE (Prematurely Ended) GB (Prematurely Ended) NL (Ongoing) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004610-29 | Sponsor Protocol Number: 2014.001 | Start Date*: 2015-02-18 |
Sponsor Name:Skanes University Hospital | ||
Full Title: Ciclosporin to Protect Renal function In Cardiac Surgery. CiPRICS. A Phase II Double Blind Randomized Placebo Controlled Study. | ||
Medical condition: Renal dysfunction after CABG surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-003468-19 | Sponsor Protocol Number: NL50040.029.14 | Start Date*: 2015-01-08 | |||||||||||
Sponsor Name:VU University Medical Center | |||||||||||||
Full Title: The effects of hyperoxia on organ dysfunction and outcome in critically ill patients with SIRS | |||||||||||||
Medical condition: Intensive Care patients with the systemic inflammatory response syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003050-41 | Sponsor Protocol Number: HJE-PHARMA-001 | Start Date*: 2015-11-10 | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: Efficacy of GLP-1 agonists and restrictive vs. liberal FiO2 in patients undergoing coronary artery bypass grafting or aortic valve replacement – a 2-by-2 factorial designed, randomized clinical study | |||||||||||||
Medical condition: We investigate the efficacy of commercially available GLP-1 analog for reducing organ damage in patients undergoing heart surgery (i.e. coronary artery bypass grafting and/or aortic valve replaceme... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004274-28 | Sponsor Protocol Number: ASK-2-2011 | Start Date*: 2011-09-21 | |||||||||||
Sponsor Name:Erling Bjerregaard Pedersen, Medicinsk forskningsafsnit, Regionshospitalet Holstebro | |||||||||||||
Full Title: Effect of hydroxyethyl starch on renal handling of sodium and water, vasoactive hormones,biomarkers and the circulatory system in patients undergoing radical prostatectomy | |||||||||||||
Medical condition: Patients undergoing radical prostatectomy in generel anesthesia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000328-85 | Sponsor Protocol Number: FINNHT1 | Start Date*: 2017-05-18 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Helsinki University Hospital, Obstetrics and Gynecology | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Randomized comparative trial between abrupt and tapered mode of discontinuation of longterm hormone therapy: Impact on endothelial function, recurrence of vasomotor symptoms and quality of life | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: We will assess the effects of hormone therapy termination on endothelial function using biophysical (flow-mediated dilation, peripheral artery tonometry) and biochemical markers. We will compare th... | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001131-31 | Sponsor Protocol Number: FHC-1-2012 | Start Date*: 2012-06-14 | |||||||||||
Sponsor Name:Department of Medical Research | |||||||||||||
Full Title: Effekts of nebivolol on the nitric oxide system in patients with essentiel hypertension | |||||||||||||
Medical condition: Essential Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002752-20 | Sponsor Protocol Number: LAN_POAF_01 | Start Date*: 2020-12-17 | |||||||||||
Sponsor Name:Medical University of Vienna | |||||||||||||
Full Title: A prospective, randomized, double- blind, placebo- controlled study to evaluate the efficacy of Landiolol hydrochloride for prevention of atrial fibrillation in patients undergoing cardiac surgery | |||||||||||||
Medical condition: Perioperative atrial fibrillation (POAF) is the most common arryhthmia after cardiac surgery with incidences ranging from 20% to 40%, depending on various patient's risk factors and the type of sur... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005600-19 | Sponsor Protocol Number: APHP200072 | Start Date*: 2022-06-17 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS | |||||||||||||
Full Title: LEvOsimendaN vs. Placebo Before Tricuspid VAlve Surgery in Patients with Right Ventricular Dysfunction | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.